Patent · US Expired

2-hydroxypropylamino-alkyl-benzimidazoly-5-yl derivatives and their use in the treatment of heart disease

US5135932A · kind A · utility

13Cited by
8References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 30, 1990
Grant dateAug 4, 1992
Priority date
Expiry dateMay 30, 2010

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The invention relates to new 2-hydroxy-n-propylamines of the formula EQU R.sub.1 --O--CH.sub.2 --CHOH--CH.sub.2 --NH--A--R.sub.2 (I) wherein PA0 R.sub.1, R.sub.2 and A are defined as in claim 1, the tautomers, enantiomers and acid addition salts thereof, particularly for pharmaceutical use the physiologically acceptable acid addition salts thereof with inorganic or organic acids, which have valuable pharmacological properties, more particularly a simultaneous cardiotonic and .beta.-blocking activity, and the use thereof as pharmaceutical compositions and processes for preparing them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.